This study assessed the risks associated with BRCA1/2 PVs for 22 first primary cancers, other than female breast and ovarian cancers, and further clarified the cancer spectrum associated with BRCA1/2 PVs. The gene discussed is BRCA1; the disease is ovarian cancer.